Pharma firm SMS Lifesciences to acquire API maker Mahi Drugs
Hyderabad-based pharmaceutical company SMS Lifesciences has said that it would acquire Mahi Drugs, which manufactures Active Pharmaceutical Ingredients (API), for an undisclosed amount. In its meeting, the board of SMS Lifesciences approved the acquisition, according to filings. Founded in 2012, Visakhapatnam-based Mahi Drugs is a non-government firm which also manufactures chemical products.